Merger/NN and/CC acquisition/NN activity/NN in/IN the/DT third/JJ quarter/NN exceeded/VBD the/DT year-earlier/JJ pace/NN ,/, said/VBD 0/-NONE- *T*-1/-NONE- Merrill/NNP Lynch/NNP &/CC Co./NNP 's/POS W.T./NNP Grimm/NNP &/CC Co./NNP unit/NN in/IN Schaumburg/NNP ,/, Ill/NNP ./.
A/DT total/NN of/IN 672/CD transactions/NNS were/VBD announced/VBN *-1/-NONE- during/IN the/DT latest/JJS quarter/NN ,/, up/RB 13/CD %/NN from/IN the/DT year-earlier/JJ period/NN 's/POS 597/CD ,/, Grimm/NNP said/VBD 0/-NONE- *T*-3/-NONE- ./.
Transactions/NNS in/IN which/WDT prices/NNS were/VBD disclosed/VBN *-1/-NONE- *T*-2/-NONE- totaled/VBD $/$ 71.9/CD billion/CD *U*/-NONE- ,/, up/RB 36/CD %/NN from/IN $/$ 52.9/CD billion/CD *U*/-NONE- a/DT year/NN earlier/RBR ,/, the/DT company/NN added/VBD 0/-NONE- *T*-3/-NONE- ./.
Grimm/NN counted/VBD 16/CD transactions/NNS valued/VBN */-NONE- at/IN $/$ 1/CD billion/CD *U*/-NONE- or/CC more/JJR *ICH*-1/-NONE- in/IN the/DT latest/JJS period/NN ,/, twice/RB as/RB many/JJ as/IN a/DT year/NN earlier/RBR ./.
The/DT largest/JJS was/VBD the/DT $/$ 12/CD billion/CD *U*/-NONE- merger/NN creating/VBG Bristol-Myers/NNP Squibb/NNP Co/NNP ./.
In/IN the/DT first/JJ nine/CD months/NNS ,/, 1,977/CD transactions/NNS were/VBD announced/VBN *-1/-NONE- ,/, up/RB 15/CD %/NN from/IN 1,716/CD in/IN the/DT year-earlier/JJ period/NN ./.
Transactions/NNS in/IN which/WDT prices/NNS were/VBD disclosed/VBN *-1/-NONE- *T*-2/-NONE- totaled/VBD $/$ 188.1/CD billion/CD *U*/-NONE- ,/, up/RB 15/CD %/NN from/IN $/$ 163.2/CD billion/CD *U*/-NONE- a/DT year/NN earlier/RBR ./.
*-1/-NONE- Citing/VBG current/JJ stock/NN market/NN conditions/NNS and/CC the/DT trend/NN away/RB from/IN highly/RB leveraged/JJ transactions/NNS ,/, Grimm/NNP said/VBD 0/-NONE- it/PRP was/VBD n't/RB certain/JJ that/IN the/DT total/JJ value/NN of/IN transactions/NNS for/IN the/DT year/NN will/MD exceed/VB the/DT record/JJ $/$ 247/CD billion/CD *U*/-NONE- in/IN 1988/CD ./.

